Literature DB >> 34011547

Unique Mutations in the Murine Hepatitis Virus Macrodomain Differentially Attenuate Virus Replication, Indicating Multiple Roles for the Macrodomain in Coronavirus Replication.

Lynden S Voth1, Joseph J O'Connor1, Catherine M Kerr1, Ethan Doerger1, Nancy Schwarting1, Parker Sperstad1, David K Johnson2, Anthony R Fehr1.   

Abstract

All coronaviruses (CoVs) contain a macrodomain, also termed Mac1, in nonstructural protein 3 (nsp3) that binds and hydrolyzes mono-ADP-ribose (MAR) covalently attached to proteins. Despite several reports demonstrating that Mac1 is a prominent virulence factor, there is still a limited understanding of its cellular roles during infection. Currently, most of the information regarding the role of CoV Mac1 during infection is based on a single point mutation of a highly conserved asparagine residue, which makes contact with the distal ribose of ADP-ribose. To determine if additional Mac1 activities contribute to CoV replication, we compared the replication of murine hepatitis virus (MHV) Mac1 mutants, D1329A and N1465A, to the previously mentioned asparagine mutant, N1347A. These residues contact the adenine and proximal ribose in ADP-ribose, respectively. N1465A had no effect on MHV replication or pathogenesis, while D1329A and N1347A both replicated poorly in bone marrow-derived macrophages (BMDMs), were inhibited by PARP enzymes, and were highly attenuated in vivo. Interestingly, D1329A was also significantly more attenuated than N1347A in all cell lines tested. Conversely, D1329A retained some ability to block beta interferon (IFN-β) transcript accumulation compared to N1347A, indicating that these mutations have different effects on Mac1 functions. Combining these two mutations resulted in a virus that was unrecoverable, suggesting that the combined activities of Mac1 are essential for MHV replication. We conclude that Mac1 has multiple functions that promote the replication of MHV, and that these results provide further evidence that Mac1 is a prominent target for anti-CoV therapeutics. IMPORTANCE In the wake of the COVID-19 epidemic, there has been a surge to better understand how CoVs replicate and to identify potential therapeutic targets that could mitigate disease caused by SARS-CoV-2 and other prominent CoVs. The highly conserved macrodomain, also termed Mac1, is a small domain within nonstructural protein 3. It has received significant attention as a potential drug target, as previous studies demonstrated that it is essential for CoV pathogenesis in multiple animal models of infection. However, the functions of Mac1 during infection remain largely unknown. Here, using targeted mutations in different regions of Mac1, we found that Mac1 has multiple functions that promote the replication of MHV, a model CoV, and, therefore, is more important for MHV replication than previously appreciated. These results will help guide the discovery of these novel functions of Mac1 and the development of inhibitory compounds targeting this domain.

Entities:  

Keywords:  ADP-ribose; ADP-ribosylation; MHV; NAD; PARP; SARS-CoV-2; coronavirus; interferon; macrodomain; mouse hepatitis virus

Mesh:

Substances:

Year:  2021        PMID: 34011547      PMCID: PMC8274620          DOI: 10.1128/JVI.00766-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Crystal structures of two coronavirus ADP-ribose-1''-monophosphatases and their complexes with ADP-Ribose: a systematic structural analysis of the viral ADRP domain.

Authors:  Yuanyuan Xu; Le Cong; Cheng Chen; Lei Wei; Qi Zhao; Xiaoling Xu; Yanlin Ma; Mark Bartlam; Zihe Rao
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

2.  PARP12 suppresses Zika virus infection through PARP-dependent degradation of NS1 and NS3 viral proteins.

Authors:  Lili Li; Hui Zhao; Ping Liu; Chunfeng Li; Natalie Quanquin; Xue Ji; Nina Sun; Peishuang Du; Cheng-Feng Qin; Ning Lu; Genhong Cheng
Journal:  Sci Signal       Date:  2018-06-19       Impact factor: 8.192

3.  Structural basis of severe acute respiratory syndrome coronavirus ADP-ribose-1''-phosphate dephosphorylation by a conserved domain of nsP3.

Authors:  Kumar Singh Saikatendu; Jeremiah S Joseph; Vanitha Subramanian; Tom Clayton; Mark Griffith; Kin Moy; Jeffrey Velasquez; Benjamin W Neuman; Michael J Buchmeier; Raymond C Stevens; Peter Kuhn
Journal:  Structure       Date:  2005-11       Impact factor: 5.006

4.  Structural, Biophysical, and Biochemical Elucidation of the SARS-CoV-2 Nonstructural Protein 3 Macro Domain.

Authors:  Meng-Hsuan Lin; San-Chi Chang; Yi-Chih Chiu; Bo-Chen Jiang; Tsung-Han Wu; Chun-Hua Hsu
Journal:  ACS Infect Dis       Date:  2020-10-05       Impact factor: 5.084

5.  The coronavirus nucleocapsid protein is ADP-ribosylated.

Authors:  Matthew E Grunewald; Anthony R Fehr; Jeremiah Athmer; Stanley Perlman
Journal:  Virology       Date:  2017-12-01       Impact factor: 3.616

6.  A family of macrodomain proteins reverses cellular mono-ADP-ribosylation.

Authors:  Gytis Jankevicius; Markus Hassler; Barbara Golia; Vladimir Rybin; Martin Zacharias; Gyula Timinszky; Andreas G Ladurner
Journal:  Nat Struct Mol Biol       Date:  2013-03-10       Impact factor: 15.369

7.  The "SARS-unique domain" (SUD) of SARS coronavirus is an oligo(G)-binding protein.

Authors:  Jinzhi Tan; Yuri Kusov; Doris Mutschall; Stefanie Tech; Krishna Nagarajan; Rolf Hilgenfeld; Christian L Schmidt
Journal:  Biochem Biophys Res Commun       Date:  2007-10-23       Impact factor: 3.575

8.  Viral macrodomains: a structural and evolutionary assessment of the pharmacological potential.

Authors:  Johannes Gregor Matthias Rack; Valentina Zorzini; Zihan Zhu; Marion Schuller; Dragana Ahel; Ivan Ahel
Journal:  Open Biol       Date:  2020-11-18       Impact factor: 6.411

9.  Mapping Physiological ADP-Ribosylation Using Activated Ion Electron Transfer Dissociation.

Authors:  Sara C Buch-Larsen; Ivo A Hendriks; Jean M Lodge; Martin Rykær; Benjamin Furtwängler; Evgenia Shishkova; Michael S Westphall; Joshua J Coon; Michael L Nielsen
Journal:  Cell Rep       Date:  2020-09-22       Impact factor: 9.423

10.  Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity.

Authors:  Collin D Heer; Daniel J Sanderson; Lynden S Voth; Yousef M O Alhammad; Mark S Schmidt; Samuel A J Trammell; Stanley Perlman; Michael S Cohen; Anthony R Fehr; Charles Brenner
Journal:  J Biol Chem       Date:  2020-10-13       Impact factor: 5.157

View more
  6 in total

1.  Design, synthesis and evaluation of inhibitors of the SARS-CoV-2 nsp3 macrodomain.

Authors:  Lavinia M Sherrill; Elva E Joya; AnnMarie Walker; Anuradha Roy; Yousef M Alhammad; Moriama Atobatele; Sarah Wazir; George Abbas; Patrick Keane; Junlin Zhuo; Anthony K L Leung; David K Johnson; Lari Lehtiö; Anthony R Fehr; Dana Ferraris
Journal:  Bioorg Med Chem       Date:  2022-05-11       Impact factor: 3.461

Review 2.  Intracellular mono-ADP-ribosyltransferases at the host-virus interphase.

Authors:  Bernhard Lüscher; Maud Verheirstraeten; Sarah Krieg; Patricia Korn
Journal:  Cell Mol Life Sci       Date:  2022-05-10       Impact factor: 9.207

3.  Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening.

Authors:  Anu Roy; Yousef M Alhammad; Peter McDonald; David K Johnson; Junlin Zhuo; Sarah Wazir; Dana Ferraris; Lari Lehtiö; Anthony K L Leung; Anthony R Fehr
Journal:  Antiviral Res       Date:  2022-05-19       Impact factor: 10.103

4.  The Reassessed Potential of SARS-CoV-2 Attenuation for COVID-19 Vaccine Development-A Systematic Review.

Authors:  Marcin Goławski; Piotr Lewandowski; Iwona Jabłońska; Marcin Delijewski
Journal:  Viruses       Date:  2022-05-07       Impact factor: 5.818

5.  Bovine Coronavirus Infects the Respiratory Tract of Cattle Challenged Intranasally.

Authors:  Katelyn R Soules; Michael C Rahe; Lisa Purtle; Craig Moeckly; Paul Stark; Clay Samson; Jeffrey P Knittel
Journal:  Front Vet Sci       Date:  2022-04-29

6.  The Conserved Macrodomain Is a Potential Therapeutic Target for Coronaviruses and Alphaviruses.

Authors:  Anthony K L Leung; Diane E Griffin; Jürgen Bosch; Anthony R Fehr
Journal:  Pathogens       Date:  2022-01-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.